Apple Watch Upgrade A Downgrade? Top Analyst Says Many Missed This Crucial Information During 'Glowtime' Event
Portfolio Pulse from Ananya Gairola
Apple's recent 'Glowtime' event unveiled the Apple Watch Series 10 and iPhone 16 series. A significant omission in the new Apple Watch is the absence of Blood Oxygen monitoring, due to a patent issue with Masimo Corporation. This could impact users upgrading from Series 6 or newer. The Apple Watch Ultra 2 offers better battery life and durability, priced slightly higher than Series 10.
September 10, 2024 | 2:52 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Masimo's patent issue with Apple over Blood Oxygen monitoring technology has led to its absence in the new Apple Watch Series 10, potentially strengthening Masimo's position in negotiations.
Masimo's patent dispute with Apple has resulted in the absence of Blood Oxygen monitoring in the new Apple Watch Series 10. This could strengthen Masimo's position in ongoing negotiations or legal proceedings, potentially benefiting the company.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 70
NEGATIVE IMPACT
Apple's new Watch Series 10 lacks Blood Oxygen monitoring due to a patent issue with Masimo, affecting users upgrading from Series 6 or newer. This could impact sales and customer satisfaction.
The absence of Blood Oxygen monitoring in the new Apple Watch Series 10 due to a legal issue with Masimo could deter potential buyers, especially those upgrading from Series 6 or newer. This could negatively impact sales and customer satisfaction in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 90